⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

20/20 Biolabs, Inc. Common Stock

$0.3410
-0.0114 (-3.23%)

Volume:

1.183K ($403.40)

Market Capitalization:

$4.35M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

20/20 Biolabs Market Segments

Premarket

-0.0190(-5.28%)
Open$0.3600
Close$0.3410
Low$0.3410
Low Change-0.0190 (-5.28%)
High$0.3600
High Change+0.0000 (+0.00%)
Range$0.0190
Volume1.183K
Dollar Volume$403.40

Overnight

+0.0000(+0.00%)
Open$0.3714
Close$0.3714
Low$0.3714
Low Change0.0000 (0.00%)
High$0.3714
High Change+0.0000 (+0.00%)
Range$0.0000
Volume200
Dollar Volume$74.28

After Hours Yesterday

-0.0086(-2.26%)
Open$0.3800
Close$0.3714
Low$0.3500
Low Change-0.0300 (-7.89%)
High$0.3800
High Change+0.0000 (+0.00%)
Range$0.0300
Volume2.707K
Dollar Volume$1.01K

Regular Trading Hours Yesterday

+0.0047(+1.35%)
Open$0.3477
Close$0.3524
Low$0.3360
Low Change-0.0117 (-3.36%)
High$0.3622
High Change+0.0145 (+4.17%)
Range$0.0262
Volume64.371K
Dollar Volume$22.68K

Premarket Yesterday

+0.0066(+1.83%)
Open$0.3600
Close$0.3666
Low$0.3600
Low Change0.0000 (0.00%)
High$0.3666
High Change+0.0066 (+1.83%)
Range$0.0066
Volume886
Dollar Volume$324.81

20/20 Biolabs Top Trades

20/20 Biolabs's top trade so far today returned +0.00%, while the top short trade returned -5.28%.

20/20 Biolabs Moving Averages

5 Day Moving Average (SMA5)$0.3866
10 Day Moving Average (SMA10)$0.4036
20 Day Moving Average (SMA20)$0.4530
50 Day Moving Average (SMA50)$0.4916
100 Day Moving Average (SMA100)$0.6249
200 Day Moving Average (SMA200)—

20/20 Biolabs Statistics

Average Volume (30 Days)—
P/E Ratio (Current)—
EPS (Current)—
Dividend Yield—
Free Cash Flow—
Cash Ratio—
Current Ratio—
Quick Ratio—
Debt to Equity—
Enterprise Value—
EV to EBITDA—
EV to Sales—
Price to Book—
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets—
Return on Equity—

20/20 Biolabs Stock Splits

There have been no stock splits for 20/20 Biolabs (AIDX).

20/20 Biolabs Dividends

There have been no dividends for 20/20 Biolabs (AIDX).